Merck & Co Inc. Blog | Talkmarkets

Latest Posts

About This Stock More About This Stock

E Rexahn's Deal With China For RX-3117 Candidate Moves It Back On The Right Track

Article By: Terry Chrisomalis

Tuesday, April 16, 2019 4:43 PM EDT

Rexahn Pharma generates a deal in Greater China for its clinical cancer product. Here's what you need to know...

In this article: RNN, MRK

Read

Week In Review: China's Cytovant Signs $1 Billion Deal For Four Medigene I-O Candidates

Article By: ChinaBio® Today

Saturday, April 6, 2019 5:16 PM EDT

Cytovant Sciences, a China cell therapy startup, announced a $1 billion partnership with Germany's Medigene to develop four of Medigene's T cell immunotherapy products in China.

In this article: MRK, NVS

Read

5 Overvalued Dow Components – April 2019

Article By: Benjamin Clark

Wednesday, April 3, 2019 10:52 AM EDT

There are so many great companies in the market today, but there are also many overvalued companies.

In this article: CVX, XOM, KO, MRK, CAT

Read

Stock Buyback Boom In 2018

Article By: David Templeton

Tuesday, March 26, 2019 11:59 AM EDT

The level of buybacks provided a tailwind for earnings growth in the fourth quarter as well as the entire calendar year 2018.

In this article: MRK, WFC, AAPL, MSFT, ORCL

Read

Biotech Stocks Hold After Brief Sell-Off Last Week…Updates

Article By: Rod Raynovich

Sunday, March 10, 2019 12:22 PM EDT

Biotech ETFs lost momentum last week but held near term support near the 20 Day moving average. Now that most companies have reported we should not expect fundamentals to create volatility.